基础医学与临床 ›› 2013, Vol. 33 ›› Issue (2): 245-248.

• 短篇综述 • 上一篇    下一篇

半乳凝素-1与自身免疫疾病

谢文珍,刘映红   

  1. 中南大学湘雅二医院肾脏病研究所
  • 收稿日期:2011-10-31 修回日期:2012-06-02 出版日期:2013-02-05 发布日期:2013-01-25
  • 通讯作者: 刘映红 E-mail:liuyingh2002@yahoo.com.cn

Galectin-1 and autoimmune disease

  • Received:2011-10-31 Revised:2012-06-02 Online:2013-02-05 Published:2013-01-25

摘要: 自身免疫性疾病是机体对自身抗原发生免疫反应而导致自身组织损害的一系列疾病,其发病机制复杂,T辅助细胞亚群失衡在其中发挥重要作用。半乳凝素-1是一种内源性糖结合蛋白,在T细胞的凋亡、信号传导及细胞因子的分泌等发挥重要的调节作用,有大量研究表明gal-1参与了自身免疫性疾病的发病机制,给予重组gal-1干预可以改善疾病的严重程度,延缓疾病进展,提示其有望成为一个新的自身免疫性疾病的治疗靶点。

关键词: galectin-1, 自身免疫, 类风湿关节炎, 系统性红斑狼疮, 糖尿病

Abstract: Autoimmune diseases arise from an inappropriate immune response of the body against the autoantigen.The pathogenesis of autoimmune disease is complicated and not well understood. However, the imbalance of T helper cell is acknowledged to be a key factor. Galectin-1, an endogenous glycan-binding protein, is known to play an important role in the T-cell survival, signaling, cytokine secretion. Recently, lots of studies demonstrate that galectin-1 also involved in the pathogenesis of autoimmune disease. Treatment with recombinant galectin-1 showed to relieve the severity and progression of some autoimmune disease animal models, which suggests that galectin-1 could be a promising therapeutic target of auto immune disease.

Key words: galectin-1, autoimmunity, rheumatoid arthritis, systemic lupus erythematosus , diabetes

中图分类号: